Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

MetLife (MET) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

FinancialsInsurance - LifeMET

Closing price · Nov 19, 2026 $97.78 -2.0% on the day · +33.6% over 12 months 52-week range $66.77 – $102.96
Get MET alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling3last 12 months
Reported sales$21.7M0 of 3 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 3, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale John D. McCallion, CFO sold 6,533 shares at $99.85 ($652K).

Trade date
Nov 18, 2026
Disclosed to the SEC
Nov 20, 2026
Type
Sale (code S)

Read the original SEC filing ↗All MET insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

MET insider transactions (Form 4)

Open-market purchases and sales. 118 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Nov 20 NewSEC John D. McCallionCFO Sell 6,533269,137 held (−2%) $99.85 $652K — —
Nov 12SEC Michel KhalafCEO, President Sell 187,425759,013 held (−20%) $102.97 $19.3M -5.0% —
Jun 3SEC Marlene DebelEvp & Chief Risk Officer Sell 21,312154,380 held (−12%) $81.59 $1.7M +19.8% —
Historical context

Similar past setups: not applicable. MET has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with MET in the Research Lab

MET has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

MET closeInsider buyInsider sale
6080100120DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-04EEarnings release filed 2026-05-06EEarnings release filed 2026-08-05EEarnings release filed 2026-11-04Sold $652,288 on 2026-11-18 · John D. McCallionSold $1,738,823 on 2026-06-01 · Marlene DebelSold $19,298,702 on 2026-11-10 · Michel Khalaf
Bought, 12 months$0
Sold, 12 months$21.7M
Insiders buying0
Insiders selling3

MetLife insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 3 sold $21.7M of MET stock on the open market; P/E 19.4 vs. a sector median of 11.9.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

MET insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $1.7M sold (1 trades)Q2 2026Q3 2026Q4 2026: $20.0M sold (2 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$20.0M2
Q3 2026—0—0
Q2 2026—0$1.7M1

Valuation, profit and volume

P/E (trailing)19.4Sector median 11.9
Market value$64.27BInsurance - Life
Profit margin4.6%Revenue growth +10.5%
Volume vs. 50-day0.9×Last 5 sessions

Source: Yahoo Finance, as of Nov 2, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 MetLife insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $21.7M. 0 of 3 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

MET earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 4, 2026 +1.7% None -0.9%S&P -2.8% pending
Aug 5, 2026 +4.0% None +4.0%S&P -0.4% -2.3%
May 6, 2026 +2.8% None -1.4%S&P +1.1% +8.0%
Feb 4, 2026 +0.9% None -2.1%S&P -1.7% -4.6%
Nov 5, 2025 +1.6% None -4.4%S&P -0.7% +3.5%
Aug 6, 2025 -1.1% None -1.4%S&P +0.7% +7.7%
Apr 30, 2025 +4.8% None -0.9%S&P +0.7% +4.5%
Feb 5, 2025 -1.9% None -1.1%S&P +0.8% -1.7%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

MET short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 30% of volume sold short2026-08-27: 27% of volume sold short2026-08-28: 58% of volume sold short2026-08-31: 53% of volume sold short2026-09-01: 46% of volume sold short2026-09-02: 44% of volume sold short2026-09-03: 53% of volume sold short2026-09-04: 56% of volume sold short2026-09-08: 43% of volume sold short2026-09-09: 50% of volume sold short2026-09-10: 59% of volume sold short2026-09-11: 68% of volume sold short2026-09-14: 66% of volume sold short2026-09-15: 73% of volume sold short2026-09-16: 66% of volume sold short2026-09-17: 65% of volume sold short2026-09-18: 75% of volume sold short2026-09-21: 52% of volume sold short2026-09-22: 44% of volume sold short2026-09-23: 58% of volume sold short2026-09-24: 60% of volume sold short2026-09-25: 68% of volume sold short2026-09-28: 61% of volume sold short2026-09-29: 51% of volume sold short2026-09-30: 52% of volume sold short2026-10-01: 45% of volume sold short2026-10-02: 49% of volume sold short2026-10-05: 48% of volume sold short2026-10-06: 56% of volume sold short2026-10-07: 67% of volume sold short2026-10-08: 62% of volume sold short2026-10-09: 64% of volume sold short2026-10-12: 57% of volume sold short2026-10-13: 39% of volume sold short2026-10-14: 30% of volume sold short2026-10-15: 48% of volume sold short2026-10-16: 51% of volume sold short2026-10-19: 59% of volume sold short2026-10-20: 66% of volume sold short2026-10-21: 64% of volume sold short2026-10-22: 52% of volume sold short2026-10-23: 40% of volume sold short2026-10-26: 31% of volume sold short2026-10-27: 62% of volume sold short2026-10-28: 46% of volume sold short2026-10-29: 38% of volume sold short2026-10-30: 64% of volume sold short2026-11-02: 51% of volume sold short2026-11-03: 56% of volume sold short2026-11-04: 50% of volume sold short2026-11-05: 61% of volume sold short2026-11-06: 52% of volume sold short2026-11-09: 57% of volume sold short2026-11-10: 31% of volume sold short2026-11-11: 49% of volume sold short2026-11-12: 49% of volume sold short2026-11-13: 47% of volume sold short2026-11-16: 60% of volume sold short2026-11-17: 64% of volume sold short2026-11-18: 52% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 52%20-day average: 50%Prior 2 months: 54%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded MET

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Alan ArmstrongSenate Bought $1,001 - $15,000 Mar 27, 2026Jul 21, 2026 +46.4%

Insiders at MetLife

InsiderBoughtSoldLast filingPast buys beat S&PScore
Michel KhalafCEO, President — $19.3M Nov 12, 2026 — —
Marlene DebelEvp & Chief Risk Officer — $1.7M Sep 2, 2026 — —
John D. McCallionCFO — $652K Nov 20, 2026 — —
Robert Glenn HubbardDirector — — Oct 5, 2026 — —
William E. KennardDirector — — Oct 5, 2026 — —
Daniel S. GlaserDirector — — Oct 5, 2026 — —
Carla A. HarrisDirector — — Oct 5, 2026 — —
Jeh C. JohnsonDirector — — Oct 5, 2026 — —
Diana McKenzieDirector — — Oct 5, 2026 1 of 1 —
Laura J. HayDirector — — Oct 5, 2026 — —
Christian Stephane MumenthalerDirector — — Oct 5, 2026 — —
Mark A. WeinbergerDirector — — Oct 5, 2026 — —
Michelle SeitzDirector — — Oct 5, 2026 — —
Ramy TadrosPresident — — Sep 10, 2026 — —
Bill PappasEvp, Global Tech. & Ops. — — Sep 2, 2026 — —
Adrienne Karen O'NeillEvp & Chief Accounting Officer — — May 4, 2026 — —
Carlos M. GutierrezDirector — — Apr 3, 2026 — —
Denise M. MorrisonDirector — — Apr 3, 2026 — —
Monica M. CurtisGeneral Counsel — — Mar 4, 2026 — —
Shurawl SibbliesEvp & Chief Hr Officer — — Mar 4, 2026 — —

Board links: companies that share insiders with MET

Directors and executives who filed Form 4s for MET and another company in the last 12 months.

See the map →
  • CMICummins Carla A. Harris Director here · Director at CMI · latest filing Oct 5, 2026
  • DGXQuest Diagnostics Denise M. Morrison Director here · Director at DGX · latest filing May 21, 2026
  • EGEverest Group Laura J. Hay Director here · Director at EG · latest filing Nov 5, 2026
  • JPMJPMorgan Chase Mark A. Weinberger Director here · Director at JPM · latest filing Oct 5, 2026
  • MSCIMsci Michelle Seitz Director here · Director at MSCI · latest filing Oct 5, 2026
  • OXYOccidental Petroleum Carlos M. Gutierrez Director here · Director at OXY · latest filing May 6, 2026
  • RJFRaymond James Financial Marlene Debel Evp & Chief Risk Officer here · Director at RJF · latest filing Sep 2, 2026
  • VVisa Denise M. Morrison Director here · Director at V · latest filing Apr 3, 2026
  • VRTXVertex Pharmaceuticals Diana McKenzie Director here · Director at VRTX · latest filing Oct 5, 2026
  • WMTWalmart Carla A. Harris Director here · Director at WMT · latest filing Oct 5, 2026

Insider activity at other Financials companies

Same sector, ranked by insider buying in the last 90 days.

  • CRBGCorebridge Financial, Inc.$376M bought
  • BPREBluerock Private Real Estate Fund$42.6M bought
  • GLXYGalaxy Digital Inc.$15.1M bought
  • PMTSCPI Card Group Inc.$12.0M bought
  • GOLDGold.com, Inc.$11.8M bought
  • PSECPROSPECT CAPITAL CORP$10.5M bought

MET stock: common questions

Are MetLife insiders buying MET stock?

No. No MetLife insider reported an open-market purchase of MET in the past 12 months.

Are MetLife insiders selling MET stock?

3 insiders reported sales worth $21.7M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is MET's P/E ratio?

MET trades at about 19.4 times trailing earnings, compared with a median of 11.9 for the Financials sector.

What is MET's 52-week range?

Over the past year MET has traded between $66.77 and $102.96. It last closed at $97.78 on Nov 19, 2026.